- List
- By Topic
- On Map
- Search Details

"gastrointestinal stromal tumor"
Need help? See RSS Feeds
Choose a feed type:

"gastrointestinal stromal tumor" (239 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02336724 | Active, not recruiting | A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
88 | All | 18 Years to 75 Years (Adult, Senior) | NCT02336724 | FMTN-II-GIST | March 2012 | December 2018 | June 2019 | January 13, 2015 | April 17, 2018 |
|
||
2 | NCT02931981 | Recruiting | Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 70 Years (Adult, Senior) | NCT02931981 | GIST-DKK4 | October 2016 | October 2016 | October 2019 | October 13, 2016 | October 13, 2016 |
|
|||
3 | NCT00954655 | Recruiting | Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001 |
|
|
Observational |
|
Other / NIH |
|
|
374 | All | 18 Years and older (Adult, Senior) | NCT00954655 | ACOSOG-Z9081 CDR0000631512 |
December 2008 | January 2100 | August 7, 2009 | August 8, 2017 |
|
||||
4 | NCT00956072 | Terminated | Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate |
|
|
Interventional | Phase 3 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT00956072 | EORTC-62063 EU-20955 EUDRACT-2007-002257-23 NOVARTIS-EORTC-62063 |
May 2009 | March 2011 | August 11, 2009 | September 24, 2012 |
|
|||
5 | NCT00573404 | Terminated | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
6 | All | 18 Years and older (Adult, Senior) | NCT00573404 | VICC GI 0621 P30CA068485 VU-VICC-GI-0621 |
July 2007 | September 2009 | March 2011 | December 14, 2007 | November 16, 2011 |
|
||
6 | NCT00685828 | Unknown † | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 3 |
|
Other |
|
|
946 | All | 18 Years and older (Adult, Senior) | NCT00685828 | EORTC-62005 AGITG-AGO102-GIST ISG-62005 SSG-15 |
January 2001 | February 2002 | May 28, 2008 | July 4, 2014 | ||||
7 | NCT03493152 | Available New |
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019) |
|
|
Expanded Access |
|
Other | Female | 18 Years and older (Adult, Senior) | NCT03493152 | CTMS# 18-0019 | April 10, 2018 | April 10, 2018 | ||||||||||
8 | NCT00568750 | Active, not recruiting | Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 2 |
|
Other |
|
|
47 | All | 18 Years to 120 Years (Adult, Senior) | NCT00568750 | SAKK 56/07 SWS-SAKK-56/07 EU-20789 EUDRACT-2007-002047-24 CDR0000577496 |
January 17, 2008 | January 18, 2012 | December 2018 | December 6, 2007 | March 2, 2018 |
|
||
9 | NCT01267695 | Completed | Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT01267695 | WJP-320.6700.09010 | May 2010 | October 2014 | October 2014 | December 28, 2010 | February 3, 2015 |
|
||
10 | NCT02763748 | Recruiting | the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | All | Child, Adult, Senior | NCT02763748 | XJTU1AF-CRF-2015-019 | June 2016 | June 2018 | December 2018 | May 5, 2016 | February 7, 2018 |
|
||
11 | NCT00976612 | Completed | Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST) |
|
|
Observational |
|
Other |
|
|
17 | All | 15 Years and older (Child, Adult, Senior) | NCT00976612 | AMC-ONCGI-0901 | January 2009 | August 2011 | December 2011 | September 14, 2009 | July 4, 2013 |
|
|||
12 | NCT03238820 | Completed | Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | All | 18 Years to 80 Years (Adult, Senior) | NCT03238820 | BE2015687GIST | January 10, 2014 | August 5, 2016 | June 1, 2017 | August 3, 2017 | August 3, 2017 |
|
||
13 | NCT02880020 | Recruiting | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02880020 | 16-000525 NCI-2016-01004 P30CA016042 |
December 2016 | September 2018 | September 2019 | August 26, 2016 | January 4, 2018 |
|
||
14 | NCT03440515 | Completed | Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Other |
|
|
29 | All | 18 Years and older (Adult, Senior) | NCT03440515 | AMC1402 | August 2014 | June 2017 | June 2017 | February 21, 2018 | February 21, 2018 | |||
15 | NCT00112632 | Completed | Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT00112632 | CDR0000430499 KRDI-TUM-GIST-CST1571-BDE43 EU-20507 |
February 2005 | June 3, 2005 | March 8, 2012 |
|
||||
16 | NCT02232620 | Active, not recruiting | A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02232620 | BBI503-205c | March 13, 2017 | December 2018 | December 2019 | September 5, 2014 | April 3, 2018 |
|
||
17 | NCT01506336 | Unknown † | A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
44 | All | 18 Years and older (Adult, Senior) | NCT01506336 | AB07001 | October 2008 | September 2011 | December 2013 | January 10, 2012 | September 26, 2012 |
|
||
18 | NCT01110668 | Completed | Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
2 | All | 18 Years and older (Adult, Senior) | NCT01110668 | CAMN107DTR01T | September 2008 | September 2011 | September 2011 | April 27, 2010 | February 28, 2017 |
|
||
19 | NCT00103168 | Unknown † | Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 3 |
|
Other |
|
|
750 | All | 18 Years and older (Adult, Senior) | NCT00103168 | EORTC-62024 ISG-62024 FRE-FNCLCC-EORTC-62024 GEIS-EORTC-62024 2004-001810-16 |
December 2004 | October 2008 | February 8, 2005 | October 29, 2013 |
|
|||
20 | NCT02268435 | Withdrawn | Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 1 |
|
Other |
|
|
0 | All | 19 Years and older (Adult, Senior) | NCT02268435 | AMC1401 | March 2015 | August 2016 | November 2016 | October 20, 2014 | August 4, 2015 | |||
21 | NCT00293124 | Completed | Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 3 |
|
Other |
|
|
125 | All | 18 Years and older (Adult, Senior) | NCT00293124 | CECOG/GIST 1.2.001 CSTI571BIC07 |
March 2004 | July 2006 | July 2008 | February 17, 2006 | August 13, 2015 |
|
||
22 | NCT00507273 | Completed | Gastrointestinal Stromal Tumors (GIST) Registry |
|
|
Observational |
|
Other / Industry |
|
|
1800 | All | Child, Adult, Senior | NCT00507273 | 2005-0294 | August 2005 | December 2010 | December 2010 | July 26, 2007 | August 2, 2012 |
|
|||
23 | NCT02365441 | Recruiting | A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
240 | All | 18 Years and older (Adult, Senior) | NCT02365441 | AG1013GST ACTRN12614000950662 |
ALT GIST | February 2015 | December 2019 | December 2020 | February 19, 2015 | October 3, 2016 |
|
|
24 | NCT02686944 | Recruiting | A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT02686944 | IM-103 2015-002689-22 |
GIST | June 2016 | June 2019 | June 2019 | February 22, 2016 | February 27, 2018 |
|
|
25 | NCT01694277 | Unknown † | A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
208 | All | 18 Years and older (Adult, Senior) | NCT01694277 | AB11002 | April 2012 | January 2015 | December 2015 | September 27, 2012 | August 14, 2013 |
|
||
26 | NCT00005597 | Completed | S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT00005597 | CDR0000067710 S9926 U10CA032102 |
April 2000 | October 2005 | October 2005 | January 27, 2003 | January 3, 2013 |
|
||
27 | NCT02576080 | Not yet recruiting | Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index |
|
|
Interventional | Phase 3 |
|
Other |
|
|
80 | All | 18 Years to 80 Years (Adult, Senior) | NCT02576080 | 2014-31 2014-005255-87 |
GIGIST | October 2015 | October 2019 | October 2020 | October 15, 2015 | October 15, 2015 | ||
28 | NCT02877368 | Completed | Sarcopenia in Patients With Gastrointestinal Stromal Tumours |
|
|
Observational |
|
Other |
|
|
31 | All | 18 Years and older (Adult, Senior) | NCT02877368 | 2015Ao003 | SARCO-GIST | May 2014 | October 2014 | October 2014 | August 24, 2016 | August 24, 2016 |
|
||
29 | NCT01275222 | Completed | Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
120 | All | 18 Years and older (Adult, Senior) | NCT01275222 | CRAD001C2206 | November 2002 | September 2008 | September 2008 | January 12, 2011 | August 8, 2016 |
|
||
30 | NCT01178307 | Active, not recruiting | Symptom Inventory for Gastrointestinal Stromal Tumors |
|
|
Observational |
|
Other / Industry |
|
|
188 | All | 18 Years and older (Adult, Senior) | NCT01178307 | 2010-0267 | July 2010 | July 2019 | July 2020 | August 10, 2010 | February 22, 2018 |
|
|||
31 | NCT00254267 | Completed | Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
35 | All | 20 Years and older (Adult, Senior) | NCT00254267 | 20050129 | November 2005 | February 2007 | December 2012 | November 16, 2005 | February 27, 2014 | |||
32 | NCT00877045 | Completed | Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting |
|
Observational |
|
Other / Industry |
|
200 | All | 18 Years and older (Adult, Senior) | NCT00877045 | SCRI OUTCOMES 01 | January 2008 | January 2009 | February 2009 | April 7, 2009 | August 4, 2010 |
|
|||||
33 | NCT01646593 | No longer available | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy |
|
|
Expanded Access |
|
Industry | All | 18 Years and older (Adult, Senior) | NCT01646593 | 16339 | July 20, 2012 | December 15, 2014 | ||||||||||
34 | NCT01689376 | No longer available | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program) |
|
|
Expanded Access |
|
Industry | All | 18 Years to 99 Years (Adult, Senior) | NCT01689376 | 16040 | September 21, 2012 | August 16, 2016 | ||||||||||
35 | NCT03158103 | Active, not recruiting | A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
3 | All | 18 Years and older (Adult, Senior) | NCT03158103 | 17-056 | April 15, 2017 | April 2020 | April 2020 | May 17, 2017 | March 23, 2018 |
|
||
36 | NCT01907607 | Active, not recruiting | Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib |
|
|
Interventional | Phase 2 |
|
Other |
|
|
63 | All | 18 Years and older (Adult, Senior) | NCT01907607 | IB 2013-01 | CYCLIGIST | August 2013 | April 2018 | April 2019 | July 25, 2013 | October 2, 2017 |
|
|
37 | NCT01396148 | Completed Has Results |
A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
6 | All | 6 Years to 20 Years (Child, Adult) | NCT01396148 | A6181196 2011-002008-33 |
June 25, 2012 | August 21, 2017 | August 21, 2017 | July 18, 2011 | March 12, 2018 | March 12, 2018 |
|
|
38 | NCT01440959 | Completed Has Results |
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
30 | All | 20 Years and older (Adult, Senior) | NCT01440959 | CTKI258AKR01T | September 2011 | March 2013 | March 2013 | September 27, 2011 | March 3, 2014 | March 3, 2014 |
|
|
39 | NCT01483014 | Completed | Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years to 70 Years (Adult, Senior) | NCT01483014 | CSTI571BBR10 | CONVERT | June 2008 | January 2012 | January 2012 | December 1, 2011 | November 18, 2016 |
|
|
40 | NCT02342600 | Withdrawn | SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor) |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT02342600 | SARC029 | January 2017 | January 2020 | January 21, 2015 | October 12, 2017 | ||||
41 | NCT00135005 | Completed | Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST) |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
59 | All | 18 Years and older (Adult, Senior) | NCT00135005 | CAMN107A2103 2005-000561-18 |
August 2005 | November 2006 | November 2006 | August 25, 2005 | May 13, 2013 |
|
||
42 | NCT01404650 | Completed Has Results |
Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT01404650 | SCRI GI 148 | December 2011 | February 2015 | February 2015 | July 28, 2011 | October 4, 2016 | October 4, 2016 |
|
|
43 | NCT01289028 | Completed Has Results |
Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
125 | All | 18 Years and older (Adult, Senior) | NCT01289028 | CAMN107DDE05 2008-000357-35 |
November 2008 | July 2014 | July 2014 | February 3, 2011 | January 2, 2017 | November 1, 2016 |
|
|
44 | NCT01172548 | Completed | Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
132 | All | 18 Years and older (Adult, Senior) | NCT01172548 | CSTI571BIC08 | INV555 | August 2008 | March 2014 | March 2014 | July 29, 2010 | May 31, 2017 |
|
|
45 | NCT01462994 | Completed | Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST) |
|
|
Interventional | Phase 3 |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT01462994 | CSTI571BDE78T | November 2011 | December 2015 | March 2016 | November 1, 2011 | March 17, 2016 |
|
||
46 | NCT01271712 | Active, not recruiting Has Results |
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
199 | All | 18 Years and older (Adult, Senior) | NCT01271712 | 14874 2009-017957-37 |
GRID | January 4, 2011 | January 26, 2012 | December 31, 2018 | January 7, 2011 | April 10, 2018 | October 25, 2013 |
|
47 | NCT01478373 | Completed Has Results |
Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
39 | All | 18 Years and older (Adult, Senior) | NCT01478373 | CTKI258AIC02 2011-001725-24 |
January 2012 | July 2014 | July 2014 | November 23, 2011 | April 27, 2016 | August 10, 2015 |
|
|
48 | NCT00237172 | Completed | Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
72 | All | 20 Years to 74 Years (Adult, Senior) | NCT00237172 | CSTI571B1202 | September 2002 | July 2005 | October 12, 2005 | May 1, 2012 | ||||
49 | NCT00812240 | Unknown † | A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
222 | All | 18 Years and older (Adult, Senior) | NCT00812240 | AB04030 | January 2009 | June 2013 | December 2013 | December 22, 2008 | September 26, 2012 |
|
||
50 | NCT01068769 | Active, not recruiting Has Results |
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
34 | All | 18 Years and older (Adult, Senior) | NCT01068769 | 09-400 | February 2010 | June 2012 | December 2018 | February 15, 2010 | March 1, 2018 | February 24, 2014 |
|
† Study has passed its completion date and status has not been verified in more than two years.